???????????????????? ???????? ????????????????: ??????????, ??????????????, ?????????????? ??????????????
Sanket Badgujar
SEO Executive | Market Research | Consulting | Analytics | Healthcare & Life Science | Pharma Industry | Medical Device | Competative Inteligence at Future Market Insights
???????????????? ???????????? ?????? ???????????????? : https://www.futuremarketinsights.com/reports/sample/rep-gb-393?utm_source=linkedin&utm_medium=419&utm_campaign=sanket
Throughout the projected period, the market for injectable medication delivery is anticipated to deepen its foundations at a constant CAGR of 8.9%. The market has a share of US$ 45.3 billion in 2023 and anticipates US$ 106.4 billion in sales by 2033. According to a research analysis on the market for injectable drug delivery, drug delivery has always been an essential component of medical services. People are becoming more aware of their health issues due to the significant rise in cases of diabetes, cardiac complications, chronic diseases like cancer, and brain tumours. As a result, the general public tries to take any measures that will aid in the treatment of their illnesses.
???????? ???? ?????? ?????? ???????????? ?????????????? ???? ???????? ???????????????? ??????:
Amgen Inc.
Antares Pharma Inc.
Becton Dickinson and Company
Consort Medical Plc (Bespak)
Crossjet
Medtronic plc,
Mylan N.V.
SHL Group
West Pharmaceutical Services
Ypsomed
The increasing prevalence of chronic illnesses and other life-threatening conditions is driving the demand for new and potent medications across a range of therapeutic areas. Injectable medication's accessibility and simplicity for use at home are driving manufacturers and pharmaceutical firms to create effective medical tools for treating a range of conditions. For instance, over the past few years, there has been a noticeable increase in the usage of injectable contraceptives. This is explained by the excellent efficacy and practicality that these injectables provide. These contraceptives can be used once a month or every three months; daily use is not required. This reason is why sales of these injectable drug delivery systems are accelerating.